⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1763992 | 0.75 | — | — | |
| SCHEMBL14684459 | 0.73 | MAPK1 (0.30) | — | |
| SCHEMBL2479770 | 0.72 | — | — | |
| SCHEMBL5930 | 0.72 | — | — | |
| SCHEMBL6513766 | 0.71 | — | — | |
| SCHEMBL8586814 | 0.70 | — | — | |
| SCHEMBL19160447 | 0.70 | — | — | |
| SCHEMBL4445861 | 0.69 | — | — | |
| SCHEMBL2453974 | 0.67 | — | — | |
| SCHEMBL1061098 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023140369-A1 | PHOSPHORIC ACID DERIVATIVES | Prism BioLab Co., Ltd. (JP) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023102523-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. (US) | 2023-06-08 | — | — | WO | disclosed |
| WO-2022191338-A1 | LEVODOPA-PRODRUGS AND CARBIDOPA-PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2022-09-15 | — | — | WO | disclosed |
| EP-3953361-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF COVID-19 | Pfizer Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| US-9809609-B2 | Water-soluble benzoazepine compound and its pharmaceutical composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9303052-B2 | Water-soluble benzoazepine compound and its pharmaceutical composition | I. OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2016-04-05 | — | — | US | disclosed |
| EP-1968990-B1 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | OTSUKA PHARMA CO LTD (JP) | 2015-02-11 | — | — | EP | disclosed |
| EP-2674436-A1 | Water-soluble benzoazepine compound and its pharmaceutical composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-12-18 | — | — | EP | disclosed |
| US-20130331358-A1 | Water-Soluble Benzoazepine Compound and Its Pharmaceutical Composition | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| US-20120277189-A1 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-11-01 | — | — | US | disclosed |
| US-20080318901-A1 | Novel Lysophosphatidic Acid Receptor Selective Antagonists | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-12-25 | — | — | US | disclosed |
| WO-2008058156-A9 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2008-12-04 | — | — | WO | disclosed |
| EP-1968990-A1 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | Otsuka Pharmaceutical Co., Ltd. (JP) | 2008-09-17 | — | — | EP | disclosed |
| WO-2008058156-A2 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1546110-A4 | COMPOUNDS ACTIVE IN SPHINGOSINE 1-PHOSPHATE SIGNALING | UNIV VIRGINIA (US) | 2008-03-26 | — | — | EP | disclosed |
| US-7241790-B2 | Compounds active in spinigosine 1-phosphate signaling | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2007-07-10 | — | — | US | disclosed |
| WO-2007074915-A1 | WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-07-05 | — | — | WO | disclosed |
| EP-1546110-A2 | COMPOUNDS ACTIVE IN SPHINGOSINE 1-PHOSPHATE SIGNALING | University of Virginia Patent Foundation (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2005041899-A2 | ORALLY AVAILABLE SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS AND ANTAGONISTS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2004010949-A2 | COMPOUNDS ACTIVE IN SPINIGOSINE 1-PHOSPHATE SIGNALING | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2004-02-05 | — | — | WO | disclosed |